Use of endovascular thrombectomy in patients with acute ischemic stroke caused by occlusions in distal vessels has failed to ...
In an editorial, J. Mocco, MD, of Mount Sinai Health System in New York City, characterized the DISTAL and ESCAPE-MeVO ...
University of Calgary researchers with the Calgary Stroke Program continue to advance the science to determine best ...
Three trials showed no improvement in functional outcomes, and the potential for harm, versus medical therapy alone.
Intensive BP lowering after successful endovascular thrombectomy for acute anterior circulation ischemic stroke did not improve 90-day functional outcomes vs. standard BP control, a speaker ...
LOS ANGELES -- For patients with large vessel occlusion (LVO) strokes, researchers found ways to make adjunctive ...
1d
News Medical on MSNESCAPE-MeVO trial advances understanding of stroke treatment for medium-sized vessel blockagesUniversity of Calgary's Hotchkiss Brain Institute researchers with the Calgary Stroke Program at Foothills Medical Centre revolutionized treatment for stroke with the ESCAPE Trial, proving that a clot ...
The American Stroke Association (ASA) announced the presentation of the DISTAL study, which is investigating whether endovascul ...
Removing a blood clot from a large brain artery, then injecting the clot-dissolving drug tenecteplase into the artery ...
Functional recovery at 90 days was lower in the balloon-guided catheter group versus the conventional catheter group. 2.
3d
PNI Atlantic News on MSNHow EVT stroke treatment expansion will benefit NL patientsTreatment for those who have suffered a stroke due to a blood clot, which has been available in St. John’s since 2022, can ...
Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke: Tacoma, Washington Friday, February 7, 2025, 18:00 Hrs [IST] Rev ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results